Brain Cancer Trial, Recruiting NCT05545007 Sponsor: Istituto Clinico Humanitas Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05545007
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have a solid tumour (a type of cancer that forms a lump or mass) confirmed by tissue testing or imaging scans
  • People for whom doctors have recommended surgery to remove one brain metastasis (a cancer growth that has spread to the brain)
  • People whose overall health and ability to carry out daily activities meets a minimum functional score, known as a Karnofsky Performance Status of 70 or above (confirm with trial site)
  • People whose cancer outside the brain is stable or responding to treatment
  • People with between 1 and 4 brain metastases in total
  • People with at least one brain metastasis measuring 2.1 cm or larger at its widest point
  • People with smaller brain metastases (2 cm or under) that are causing pressure on the brain, neurological symptoms, or significant swelling that has not improved with steroid medication
  • People who are able to provide written agreement to participate in the trial

Who may not be able to join:

  • People who have previously had whole-brain radiation therapy (a treatment that delivers radiation across the entire brain)
  • People whose overall health and functional ability falls below the minimum Karnofsky Performance Status score of 70
  • People diagnosed with small cell lung cancer, germ cell tumours, or cancers affecting the lymphatic system (such as lymphoma)
  • People who are pregnant
  • People who have previously had open brain surgery for cancer
  • People with more than 4 brain metastases
  • People who are unable to have an MRI scan for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 028224 7458

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Clinico Humanitas
Registry
ClinicalTrials.gov
Start date
31 January 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Rate of LMD (leptomeningeal disease) occurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov